Clinical Trials Browser

Recruiting × ravulizumab × 90 days × Clear all

NCT06909253 2026-05-15

MG-ARCADIA

Myasthenia Gravis

NCT06312644 2026-04-16

Study of Ultomiris® (Ravulizumab) Safety in Pregnancy

Classical hematology

Hemoglobinuria, Paroxysmal, Myasthenia Gravis, Neuromyelitis Optica, Atypical Hemolytic Uremic Syndrome

NCT07221838 2026-04-09

OCTAGON

Phase 4 Recruiting

Adrenal Insufficiency, Myasthenia Gravis